We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.37B
AUM Growth
-$224M
Cap. Flow
-$309M
Cap. Flow %
-22.53%
Top 10 Hldgs %
17.96%
Holding
216
New
21
Increased
69
Reduced
53
Closed
28

Top Buys

Rank Stock Value
1
DNA icon
Ginkgo Bioworks
DNA
+$29M
2
MXCT icon
MaxCyte
MXCT
+$14.8M
3
SKIN icon
SkinHealth Systems
SKIN
+$8.7M
4
JBTM
JBT Marel
JBTM
+$7.82M
5
EXE
Expand Energy Corp
EXE
+$7.8M

Top Sells

Rank Stock Value
1
ZLAB icon
Zai Lab
ZLAB
+$25.1M
2
INSP icon
Inspire Medical Systems
INSP
+$21.2M
3
TXG icon
10x Genomics
TXG
+$21.1M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$20.2M
5
TRIL
Trillium Therapeutics Inc.
TRIL
+$13.4M

Sector Composition

Rank Sector Weight
1 Healthcare 35.81%
2 Technology 14.81%
3 Financials 9.02%
4 Industrials 8.86%
5 Consumer Discretionary 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TLIS
76
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$6.18M 0.45%
65,939
-5,482
-8% -$730K
CELL
77
DELISTED
PhenomeX Inc. Common Stock
CELL
$6.12M 0.45%
312,824
-145,552
-32% -$5.54M
LRCX icon
78
Lam Research
LRCX
$390B
$6.05M 0.44%
106,340
+540
+0.5% +$32.8K
AMZN icon
79
Amazon
AMZN
$2.96T
$6.02M 0.44%
36,660
+30,340
+480% +$5.23M
DSGX icon
80
Descartes Systems
DSGX
$6.82B
$5.84M 0.43%
71,910
+2,316
+3% +$175K
XYZ
81
Block Inc
XYZ
$47.5B
$5.75M 0.42%
23,984
+674
+3% +$173K
ASML icon
82
ASML
ASML
$669B
$5.75M 0.42%
7,714
+261
+4% +$205K
PACW
83
DELISTED
PacWest Bancorp
PACW
$5.7M 0.42%
125,846
+5,738
+5% +$238K
MSFT icon
84
Microsoft
MSFT
$3.71T
$5.38M 0.39%
19,090
+5,331
+39% +$1.55M
FSS icon
85
Federal Signal
FSS
$7.83B
$5.3M 0.39%
137,156
+33,165
+32% +$1.3M
TWLO icon
86
Twilio
TWLO
$36.6B
$5.18M 0.38%
16,251
-3,428
-17% -$1.25M
HOWL icon
87
Werewolf Therapeutics
HOWL
$19.3M
$5.08M 0.37%
296,283
+1,629
+0.6% +$27.8K
JPM icon
88
JPMorgan Chase
JPM
$950B
$4.91M 0.36%
+30,000
New +$4.7M
UMH
89
UMH Properties
UMH
$1.36B
$4.78M 0.35%
+208,720
New +$4.87M
APO icon
90
Apollo Global Management
APO
$73.4B
$4.62M 0.34%
75,000
– –
LNW
91
DELISTED
Light & Wonder
LNW
$4.47M 0.33%
+53,808
New +$3.79M
ASND icon
92
Ascendis Pharma A/S
ASND
$16.8B
$4.33M 0.32%
+27,134
New +$3.71M
MTCH icon
93
Match Group
MTCH
$8.55B
$4.22M 0.31%
26,903
+775
+3% +$118K
PRU icon
94
Prudential Financial
PRU
$41.8B
$4.21M 0.31%
40,000
– –
TSM icon
95
TSMC
TSM
$2.18T
$4.19M 0.31%
37,496
+1,250
+3% +$147K
VRRM icon
96
Verra Mobility
VRRM
$744M
$4.08M 0.3%
270,568
+74,116
+38% +$1.13M
SI
97
DELISTED
Silvergate Capital Corporation
SI
$4.02M 0.29%
+34,770
New +$3.72M
AFG icon
98
American Financial Group
AFG
$12.1B
$3.95M 0.29%
31,370
-27,977
-47% -$3.65M
XBI icon
99
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$3.93M 0.29%
+31,247
New +$4.02M
CSGP icon
100
CoStar Group
CSGP
$12.3B
$3.91M 0.29%
45,483
+12,923
+40% +$1.12M
2 3
4
5 6

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Nicholas Investment Partners held 216 positions worth $1.37B, down 14% from $1.59B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nicholas Investment Partners withdrew a net $309M in Q3 2021, closing 28 positions and reducing 53 holdings. Its most notable exit was Zai Lab, an estimated $25.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 45% a quarter earlier, followed by Technology and Financials.

Against the trend, Nicholas Investment Partners opened a new position in Ginkgo Bioworks worth $27.6M.

  • Nicholas Investment Partners's largest Q3 2021 buy was Ginkgo Bioworks: 59,532 shares worth $27.6M.
  • Nicholas Investment Partners added most to Expand Energy Corp in Q3 2021, an estimated $7.8M increase.
  • Nicholas Investment Partners's biggest Q3 2021 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $20.2M.
  • Nicholas Investment Partners fully exited Zai Lab in Q3 2021, selling an estimated $25.1M.
  • Nicholas Investment Partners's ten largest holdings make up 18% of its $1.37B portfolio in Q3 2021.
  • Nicholas Investment Partners opened 21 new positions and closed 28 in Q3 2021.
  • Nicholas Investment Partners's portfolio value fell 14% quarter-over-quarter to $1.37B.

Based on Nicholas Investment Partners's 13F filing for Q3 2021, filed 15 Nov 2021.